| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 6.494 | 11.047 |
| Total Income - EUR | - | - | - | - | - | - | - | 5.305 | 15.149 | 15.742 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 5.064 | 13.951 | 16.026 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 241 | 1.198 | -283 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 241 | 1.198 | -615 |
| Employees | - | - | - | - | - | - | - | 2 | 1 | 1 |
Check the financial reports for the company - Neuromedcris S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 25.909 | 26.556 | 21.648 |
| Current Assets | - | - | - | - | - | - | - | 11.165 | 2.424 | 2.068 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 9.817 | 0 | 0 |
| Cash | - | - | - | - | - | - | - | 1.348 | 2.424 | 2.068 |
| Shareholders Funds | - | - | - | - | - | - | - | 444 | 1.637 | 1.012 |
| Social Capital | - | - | - | - | - | - | - | 203 | 202 | 201 |
| Debts | - | - | - | - | - | - | - | 2.269 | 1.741 | 1.941 |
| Income in Advance | - | - | - | - | - | - | - | 34.361 | 25.602 | 20.763 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuromedcris S.r.l.